THEMISMED — Themis Medicare Income Statement
0.000.00%
- IN₹9.93bn
- IN₹10.69bn
- IN₹4.06bn
- 65
- 13
- 23
- 20
Annual income statement for Themis Medicare, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 2,307 | 3,946 | 3,543 | 3,818 | 4,055 |
| Cost of Revenue | |||||
| Gross Profit | 1,435 | 2,261 | 2,194 | 2,268 | 2,551 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 1,897 | 3,085 | 2,974 | 3,425 | 3,664 |
| Operating Profit | 409 | 862 | 570 | 393 | 391 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 413 | 953 | 725 | 534 | 397 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 357 | 729 | 569 | 435 | 298 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | 357 | 729 | 569 | 435 | 298 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 357 | 729 | 569 | 435 | 298 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 3.88 | 7.91 | 6.17 | 4.72 | 3.24 |
| Dividends per Share |